TY  - GEN
AU  - Frampton,James E
TI  - Ranibizumab: a review of its use in the treatment of neovascular age-related macular degeneration
SN  - 1179-1969
PY  - 2013///1031
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - economics
KW  - Choroidal Neovascularization
KW  - drug therapy
KW  - Cost-Benefit Analysis
KW  - Drug Administration Schedule
KW  - Europe
KW  - Humans
KW  - Macular Degeneration
KW  - Multicenter Studies as Topic
KW  - Randomized Controlled Trials as Topic
KW  - Ranibizumab
KW  - Treatment Outcome
KW  - United States
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1007/s40266-013-0077-9
ER  -